BeOne Medicines Ltd. (ONC): Capital Expenditures
$185.84M
Year ended 2025-12-31
$153.87M
Trailing 12 months to 2026-06-30
-17.0%
3-year compound annual growth
+9.6%
5-year compound annual growth
+42.7%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $185.84M | -62.3% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $492.66M | -12.3% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $561.90M | +72.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $325.43M | +23.8% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $262.94M | +123.8% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $117.51M | +31.1% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $89.61M | +27.5% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $70.28M | +51.6% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $46.37M | +97.3% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $23.50M | +342.3% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $5.31M | +712.5% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $654.0K | n/a | 2017-03-22, From 2014-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $185.84M | -62.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $276.00M | +87.8% |
| Organon & Co. (OGN) | 2025-12-31 | $162.00M | -7.4% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $58.75M | +54.3% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $93.40M | -21.0% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $58.70M | +71.2% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $103.04M | +20.6% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $520.50M | +111.2% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $70.06M | +34.9% |
Compare ONC, ELAN, OGN, JAZZ side by side · Screen every company in Pharmaceutical Preparations ↗